Literatura académica sobre el tema "Radioembolisation hépatique"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Radioembolisation hépatique".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Radioembolisation hépatique":
Vesselle, G., I. Petit, S. Boucebci, T. Rocher, S. Velasco y J. P. Tasu. "Radioembolisation hépatique à l’Yttrium-90 : guide pratique et revue de littérature". Journal de Radiologie Diagnostique et Interventionnelle 96, n.º 2 (junio de 2015): 119–34. http://dx.doi.org/10.1016/j.jradio.2014.01.012.
Pernot, S., O. Pellerin, N. Ghazzar, J. N. Vaillant, C. Lepère, M. Sapoval, J. Taieb y P. Rougier. "Chimiothérapie intra-artérielle hépatique, chimioembolisation et radioembolisation : un apport important pour le traitement des métastases hépatiques des cancers colorectaux". Oncologie 16, n.º 11-12 (diciembre de 2014): 571–78. http://dx.doi.org/10.1007/s10269-014-2468-x.
Lenoir, L., J. Edeline, Y. Rolland, H. Mesbah, P. Poree, S. Laffont, M. Pracht, V. Ardisson, E. Boucher y E. Garin. "Radioembolisation du CHC : prédiction de la réponse et de la survie par la scintigraphie de perfusion hépatique (TEMP/TDM) aux MAA-99mTc". Médecine Nucléaire 36, n.º 4 (abril de 2012): 166. http://dx.doi.org/10.1016/j.mednuc.2012.02.032.
Ilonca, A. D., M. Fourcade, D. De Verbizier Lonjon, E. Delhom, B. Guiu y D. Mariano Goulart. "Radioembolisation hépatique en vue d’une lobectomie radique à l’aide des microsphères en résine chargées en Y90 pour un hépatocarcinome avec thrombose portale droite tumorale". Médecine Nucléaire 40, n.º 3 (mayo de 2016): 195. http://dx.doi.org/10.1016/j.mednuc.2016.03.071.
Lenoir, L., Y. Rolland, S. Laffont, V. Ardisson, E. Boucher, J. L. Raoul y E. Garin. "Radioembolisation des tumeurs hépatiques par microsphères marquées à l’yttrium-90". Médecine Nucléaire 35, n.º 4 (abril de 2011): 224–31. http://dx.doi.org/10.1016/j.mednuc.2011.02.013.
Roux, J., L. Djaïleb, M. D. Desruet, C. Gallazzini-Crepin y J. P. Vuillez. "Quelle place pour la radioembolisation Yttrium 90 dans le traitement des métastases hépatiques du cancer colorectal ?" Médecine Nucléaire 40, n.º 6 (noviembre de 2016): 416–19. http://dx.doi.org/10.1016/j.mednuc.2016.09.003.
Schaefer, NG y T. Pfammatter. "Radioembolisation transartérielle des carcinomes hépatiques par sphères de résine Y-90 (sphères SIR)". Forum Médical Suisse ‒ Swiss Medical Forum 10, n.º 41 (13 de octubre de 2010). http://dx.doi.org/10.4414/fms.2010.07307.
Tesis sobre el tema "Radioembolisation hépatique":
Hammami, Houda. "Guidance of radioembolization procedures in the context of interventional oncology". Thesis, Rennes 1, 2021. http://www.theses.fr/2021REN1S121.
Radioembolization is a minimally-invasive intervention performed to treat liver cancer by administering radioactive microspheres. In order to optimize radioembolization outcomes, the procedure is carried out in two sessions: pretreatment assessment intervention, mainly performed to locate the injection site, assess microspheres distribution and perform dosimetry evaluation, and treatment intervention performed to inject the estimated proper dose of radioactive microspheres in the located injection site. Due to the hepatic vasculature complexity, interventional radiologists carefully manipulate the catheter, during the two interventions, under X-Ray image guidance and resort to contrast media injection in order to highlight vessels. In this thesis, we propose a novel guidance strategy that promises a simplification and accuracy of the catheter navigation during the pretreatment assessment, as well as during the treatment interventions. The proposed navigation system processes pre- and intraoperative images to achieve intraoperative image fusion through a rigid registration technique. This approach is designed to 1) assist the celiac trunk access, 2) assist the injection site access and 3) automatically reproduce the injection site during the proper intervention. Knowing that the liver undergoes a motion induced by the breathing, we also propose an approach that allows obtaining a dynamic overlay of the projected 3D vessels onto fluoroscopy
Verger, Elise. "Microparticules à base d’amidon (SBMP) comme agent théranostique unique pour la radiothérapie sélective interne des tumeurs hépatiques : radiomarquage au gallium-68 et rhénium-188 et étude préliminaire in vivo". Thesis, Angers, 2016. http://www.theses.fr/2016ANGE0054/document.
The Hepatocellular Carcinoma has a high incidence worldwide and is associated with a bad prognostic. The existing curative treatments can only be apply in a minority of cases. The selective internal radiation therapy (SIRT) is a palliative treatment that is increasingly used. This technique is define by the selective intratumoral injection of yttrium-90microspheres via intra-arterial infusion. It involves two steps : a pre-therapeutic one for treatment simulation purpose with the injection of serum albumin macroaggregates radiolabeled with 99mTc and the treatment itself. However the characteristics of these two vectors are different and can lead to variations in biodistribution and approximate dosimetry. This works aims to develop a unique radiotheranostic vector for the SIRT: the starch-basedmicroparticles (SBMP), in order to overcome the different currents clinical problems. The optimization of the radiolabeling by the 68Ga and the 188Re in the form of ready-to-use radiolabeling kits allowed to obtain a radiochemical purity > 98 % and > 95 % respectively. A preliminary in vivo study by PET/CT imaging in rat, following the intra-arterial injection of 68Ga-SBMP displayed a specific biodistribution of the microparticles with more than 95 % of the activity found in the liver and mostly in the tumors. The SBMP offer several advantages that answer different current issues and area promising theranostic agent for the SIRT. A presentation of the SIRT, the different microparticles in development and the existing animal models of hepatic tumor will also be developed in this work